Generic competition, charges cut Merc...

Generic competition, charges cut Merck Q4 profit

Merck & Co.'s fourth-quarter profit fell 7 percent because of hits from generic competition and one-time charges, and the company pushed back plans for seeking approval of a key experimental osteoporosis drug.

Start the conversation, or Read more at WDBO-AM Orlando.

More from around the web